Citigroup’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.23M | Buy |
|
|||||
|
2025
Q2 | $490K | Sell |
|
|||||
|
2025
Q1 | $588K | Buy |
|
|||||
|
2024
Q4 | $450K | Buy |
|
|||||
|
2024
Q3 | $200K | Buy |
|
|||||
|
2024
Q2 | $47.5K | Sell |
|
|||||
|
2024
Q1 | $344K | Sell |
|
|||||
|
2023
Q4 | $379K | Buy |
|
|||||
|
2023
Q3 | $174K | Buy |
|
|||||
|
2023
Q2 | $45 | Hold |
|
|||||
|
2023
Q1 | $27 | Sell |
|
|||||
|
2022
Q4 | $419 | Sell |
|
|||||
|
2022
Q3 | $15K | Sell |
|
|||||
|
2022
Q2 | $39K | Sell |
|
|||||
|
2022
Q1 | $170K | Sell |
|
|||||
|
2021
Q4 | $1.53M | Buy |
|
|||||
|
2021
Q3 | $1.29M | Sell |
|
|||||
|
2021
Q2 | $3.46M | Sell |
|
|||||
|
2021
Q1 | $3.84M | Buy |
|
|||||
|
2020
Q4 | $123K | Buy |
|
|||||
|
2020
Q3 | $39K | Sell |
|
|||||
|
2020
Q2 | $8.26M | Buy |
|
|||||
|
2020
Q1 | $744K | Buy |
|
|||||
|
2019
Q4 | $425K | Sell |
|
|||||
|
2019
Q3 | $1.27M | Sell |
|
|||||
|
2019
Q2 | $1.65M | Buy |
|
|||||
|
2019
Q1 | $318K | Sell |
|
|||||
|
2018
Q4 | $1.65M | Buy |
|
|||||
|
2018
Q3 | $455K | Buy |
|
|||||
|
2018
Q2 | $444K | Buy |
|
|||||
|
2018
Q1 | $342K | Sell |
|
|||||
|
2017
Q4 | $629K | Buy |
|
|||||
|
2017
Q3 | $537K | Buy |
|
|||||
|
2017
Q2 | $57K | Buy |
|
|||||
|
2017
Q1 | $3K | Sell |
|
|||||
|
2016
Q4 | $94K | Buy |
|
|||||
|
2016
Q3 | $0 | Sell |
|
|||||
|
2016
Q2 | $61K | Sell |
|
|||||
|
2016
Q1 | $208K | Buy |
|
|||||
|
2015
Q4 | $121K | Buy |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $42K | Buy |
|
|||||
|
2015
Q1 | $34K | Sell |
|
|||||
|
2014
Q4 | $65K | Buy |
|
|||||
|
2014
Q3 | $6K | Buy |
|
|||||
|
2014
Q2 | $3K | Buy |
|